103 related articles for article (PubMed ID: 31308027)
1. Tumor Abnormal Protein in the Diagnosis of Breast Cancer in Patients with a Palpable Mass.
Chen WX; Yang LG; Cheng L; Zhu YL
Ann Clin Lab Sci; 2019 May; 49(3):297-301. PubMed ID: 31308027
[TBL] [Abstract][Full Text] [Related]
2. Tumor Abnormal Protein as a Novel Biomarker in Papillary Thyroid Carcinoma.
Liu Z; Cai J; Yu Y; Fang H; Si Y; Jankee JJ; Shen M
Clin Lab; 2017 Mar; 63(3):479-485. PubMed ID: 28271680
[TBL] [Abstract][Full Text] [Related]
3. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
[TBL] [Abstract][Full Text] [Related]
4. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282
[TBL] [Abstract][Full Text] [Related]
5. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
6. RACK1: A superior independent predictor for poor clinical outcome in breast cancer.
Cao XX; Xu JD; Liu XL; Xu JW; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Int J Cancer; 2010 Sep; 127(5):1172-9. PubMed ID: 20020495
[TBL] [Abstract][Full Text] [Related]
7. Rate of metastasis in examined lymph nodes as a predictor of extracapsular extension in patients with axillary node-positive breast cancer.
Unal D; Oguz A; Tasdemir A
J Nippon Med Sch; 2014; 81(6):372-7. PubMed ID: 25744480
[TBL] [Abstract][Full Text] [Related]
8. Receiver-operating characteristic (ROC) curve analysis of cathepsin D and pS2 in breast disease; results from a prospective study.
Eskelinen M; Kataja V; Hämäläinen E; Kosma VM
Anticancer Res; 1999; 19(4C):3463-7. PubMed ID: 10629636
[TBL] [Abstract][Full Text] [Related]
9. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
10. Comparison of early and delayed quantified indices of double-phase (99m)Tc MIBI scintimammography in the detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Acta Radiol; 2005 Apr; 46(2):148-54. PubMed ID: 15902889
[TBL] [Abstract][Full Text] [Related]
11. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of benign and metastatic axillary lymph nodes in breast cancer: additive value of MRI computer-aided evaluation.
Yun SJ; Sohn YM; Seo M
Clin Radiol; 2016 Apr; 71(4):403.e1-7. PubMed ID: 26875621
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.
Coutant C; Rouzier R; Fondrinier E; Marchal F; Guillemin F; Seince N; Rodrigues A; Darai E; Uzan S; Barranger E
Breast Cancer Res Treat; 2009 Feb; 113(3):537-43. PubMed ID: 18340527
[TBL] [Abstract][Full Text] [Related]
14. The Relevance of Ultrasound Imaging of Suspicious Axillary Lymph Nodes and Fine-needle Aspiration Biopsy in the Post-ACOSOG Z11 Era in Early Breast Cancer.
Vijayaraghavan GR; Vedantham S; Kataoka M; DeBenedectis C; Quinlan RM
Acad Radiol; 2017 Mar; 24(3):308-315. PubMed ID: 27916595
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
[TBL] [Abstract][Full Text] [Related]
16. Insights into the role of tumor abnormal protein in early diagnosis of cancer: A prospective cohort study.
Li LX; Zhang B; Gong RZ
Medicine (Baltimore); 2020 Mar; 99(11):e19382. PubMed ID: 32176062
[TBL] [Abstract][Full Text] [Related]
17. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
[TBL] [Abstract][Full Text] [Related]
18. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
19. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
